From: Comparing DNA methylation profiles in saliva and intestinal mucosa
Patient | Age range | BMI | Ethnicity | Smoking Status | Reason for endoscopy | Medications |
---|---|---|---|---|---|---|
One | 65–74 | 30.0 | Caucasian | Quit | Difficulty swallowing | Somac, Warfarin |
Two | 65–74 | 33.6 | Caucasian | Never | Epigastric pain |  |
Three | 65–74 | 39.9 | Caucasian | Never | Epigastric pain | Nexium |
Four | 45–54 | 28.4 | Caucasian | Quit | Oesophageal reflux | Somac |
Five | 18–25 | 25.4 | Caucasian | Never | Oesophageal reflux | Nexium, Motilium, Mezavart |
Six | 45–54 | 30.1 | Caucasian | Never | Routine follow up for coeliac disease |  |
Seven | 35–44 | 26.3 | Caucasian | Quit | Routine follow up for coeliac disease |  |
Eight | 55–64 | 24.3 | Caucasian | Never | Routine follow up for coeliac disease |  |
Nine | 65–74 | 29.0 | Caucasian | Quit | Routine follow up for coeliac disease |  |
Ten | 18–25 | 17.8 | Caucasian | Never | Routine follow up for coeliac disease |  |